Home › Trial NCT07514975
First-In-Human Study of KHN922 for Injection
- Trial IDNCT07514975
- StatusNot Yet Recruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorChengdu Kanghong Biotech Co., Ltd.
- Enrollment276
- Start date2026-04
- ConditionsAdvanced Solid Tumors Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.